ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY

Abstract Metastasis is the predominant reason for high mortality of hepatocellular carcinoma (HCC) patients. It is critical to explore the molecular mechanism underlying HCC metastasis. Here, we reported that transcription factor One Cut homeobox 2 (ONECUT2) functioned as an oncogene to facilitate H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Danfei Liu, Tongyue Zhang, Xiaoping Chen, Bixiang Zhang, Yijun Wang, Meng Xie, Xiaoyu Ji, Mengyu Sun, Wenjie Huang, Limin Xia
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/083c4832605540b6b7b35b669e9cf123
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:083c4832605540b6b7b35b669e9cf123
record_format dspace
spelling oai:doaj.org-article:083c4832605540b6b7b35b669e9cf1232021-11-28T12:04:25ZONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY10.1038/s41419-021-04410-32041-4889https://doaj.org/article/083c4832605540b6b7b35b669e9cf1232021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04410-3https://doaj.org/toc/2041-4889Abstract Metastasis is the predominant reason for high mortality of hepatocellular carcinoma (HCC) patients. It is critical to explore the molecular mechanism underlying HCC metastasis. Here, we reported that transcription factor One Cut homeobox 2 (ONECUT2) functioned as an oncogene to facilitate HCC metastasis. Elevated ONECUT2 expression was positively correlated with increased tumor number, tumor encapsulation loss, microvascular invasion, poor tumor differentiation, and advanced TNM stage. Mechanistically, ONECUT2 directly bound to the promoters of fibroblast growth factor 2 (FGF2) and ATP citrate lyase (ACLY) and transcriptionally upregulated their expression. Knockdown of FGF2 and ACLY inhibited ONECUT2-mediated HCC metastasis, whereas upregulation of FGF2 and ACLY rescued ONECUT2 knockdown-induced suppression of HCC metastasis. ONECUT2 expression was positively correlated with FGF2 and ACLY expression in human HCC tissues. HCC patients with positive coexpression of ONECUT2/FGF2 or ONECUT2/ACLY exhibited the worst prognosis. In addition, FGF2 upregulated ONECUT2 expression through the FGFR1/ERK/ELK1 pathway, which formed an FGF2-FGFR1-ONECUT2 positive feedback loop. Knockdown of ONECUT2 inhibited FGF2-induced HCC metastasis. Furthermore, the combination of FGFR1 inhibitor PD173074 with ACLY inhibitor ETC-1002 markedly suppressed ONECUT2-mediated HCC metastasis. In summary, ONECUT2 was a potential prognostic biomarker in HCC and targeting this oncogenic signaling pathway may provide an efficient therapeutic strategy against HCC metastasis.Danfei LiuTongyue ZhangXiaoping ChenBixiang ZhangYijun WangMeng XieXiaoyu JiMengyu SunWenjie HuangLimin XiaNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 12, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Danfei Liu
Tongyue Zhang
Xiaoping Chen
Bixiang Zhang
Yijun Wang
Meng Xie
Xiaoyu Ji
Mengyu Sun
Wenjie Huang
Limin Xia
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
description Abstract Metastasis is the predominant reason for high mortality of hepatocellular carcinoma (HCC) patients. It is critical to explore the molecular mechanism underlying HCC metastasis. Here, we reported that transcription factor One Cut homeobox 2 (ONECUT2) functioned as an oncogene to facilitate HCC metastasis. Elevated ONECUT2 expression was positively correlated with increased tumor number, tumor encapsulation loss, microvascular invasion, poor tumor differentiation, and advanced TNM stage. Mechanistically, ONECUT2 directly bound to the promoters of fibroblast growth factor 2 (FGF2) and ATP citrate lyase (ACLY) and transcriptionally upregulated their expression. Knockdown of FGF2 and ACLY inhibited ONECUT2-mediated HCC metastasis, whereas upregulation of FGF2 and ACLY rescued ONECUT2 knockdown-induced suppression of HCC metastasis. ONECUT2 expression was positively correlated with FGF2 and ACLY expression in human HCC tissues. HCC patients with positive coexpression of ONECUT2/FGF2 or ONECUT2/ACLY exhibited the worst prognosis. In addition, FGF2 upregulated ONECUT2 expression through the FGFR1/ERK/ELK1 pathway, which formed an FGF2-FGFR1-ONECUT2 positive feedback loop. Knockdown of ONECUT2 inhibited FGF2-induced HCC metastasis. Furthermore, the combination of FGFR1 inhibitor PD173074 with ACLY inhibitor ETC-1002 markedly suppressed ONECUT2-mediated HCC metastasis. In summary, ONECUT2 was a potential prognostic biomarker in HCC and targeting this oncogenic signaling pathway may provide an efficient therapeutic strategy against HCC metastasis.
format article
author Danfei Liu
Tongyue Zhang
Xiaoping Chen
Bixiang Zhang
Yijun Wang
Meng Xie
Xiaoyu Ji
Mengyu Sun
Wenjie Huang
Limin Xia
author_facet Danfei Liu
Tongyue Zhang
Xiaoping Chen
Bixiang Zhang
Yijun Wang
Meng Xie
Xiaoyu Ji
Mengyu Sun
Wenjie Huang
Limin Xia
author_sort Danfei Liu
title ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
title_short ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
title_full ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
title_fullStr ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
title_full_unstemmed ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
title_sort onecut2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating fgf2 and acly
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/083c4832605540b6b7b35b669e9cf123
work_keys_str_mv AT danfeiliu onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT tongyuezhang onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT xiaopingchen onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT bixiangzhang onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT yijunwang onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT mengxie onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT xiaoyuji onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT mengyusun onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT wenjiehuang onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
AT liminxia onecut2facilitateshepatocellularcarcinomametastasisbytranscriptionallyupregulatingfgf2andacly
_version_ 1718408180168392704